Previous 10 | Next 10 |
-- Total offering size of $963.5 million -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the closing of its underwritten public offering of 13,570,000 of its ordinary shares at a price to the public of $71.00 per share. This includes the exercise in full by the underwriters of...
Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named to the Crain’s Chicago Business 2020 Best Places to Work in Chicago list. “It’s a tremendous honor that Crain’s Chicago Business ranked us among the Best Places to Work in Chicag...
Horizon Therapeutics (NASDAQ: HZNP ) has priced its public offering of 11.8M ordinary shares at $71.00/share, for expected net proceeds of ~$798.9M. More news on: Horizon Therapeutics Public Limited Company, Healthcare stocks news, , Read more ...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the pricing of its underwritten public offering of 11,800,000 of its ordinary shares at a price to the public of $71.00 per share. The net proceeds to the Company from this offering are expected to be approximately $798.9 million, after ...
Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named to the 2020 Fortune Best Workplaces for Millennials™ list . Horizon ranked 7 th among 25 companies in the small and medium company category in its first year on the list. “We’re proud...
Image source: The Motley Fool. Horizon Therapeutics PLC (NASDAQ: HZNP) Q2 2020 Earnings Call Aug 5, 2020 , 8:00 a.m. ET Operator Continue reading
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it is offering to sell $700,000,000 of its ordinary shares in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $105,000,000 of ordinary shares in the...
Horizon Therapeutics PLC (HZNP) Q2 2020 Earnings Conference Call August 05, 2020, 08:00 ET Company Participants Tina Ventura - SVP, IR Timothy Walbert - Chairman, President & CEO Elizabeth Thompson - Group VP, Clinical Development & External Search Paul Hoelscher - EVP ...
The following slide deck was published by Horizon Therapeutics Public Limited Company in conjunction with their 2020 Q2 earnings Read more ...
Horizon Therapeutics ( HZNP ) Q2 results : More news on: Horizon Therapeutics Public Limited Company, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...